mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.002 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.003 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.49 |
0.005 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.006 |